Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.

about

Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.

Item

http://www.wikidata.org/entity/Q38749061

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Optimizing Symptoms and Manage ...... Status and Future Directions.

@en

type

Item

label

Optimizing Symptoms and Manage ...... Status and Future Directions.

@en

prefLabel

Optimizing Symptoms and Manage ...... Status and Future Directions.

@en

P1476

Optimizing Symptoms and Manage ...... Status and Future Directions.

@en

P2093

Alexandre Chan

http://www.w3.org/2001/XMLSchema#string

Xiao Jun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Colony-stimulating factors for chemotherapy-induced febrile neutropenia

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia

The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials

Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.

Chemotherapy dose reduction and delay in clinical practice. evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer.

Economic burden of haematological adverse effects in cancer patients: a systematic review.

The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

P2888

s11912-017-0578-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-017-0578-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084033424

http://www.w3.org/2001/XMLSchema#string

P698

28271398

http://www.w3.org/2001/XMLSchema#string

Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.

about

Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698